Market by Source, Product, Application, and Country Outlook | Forecast 2022-2028
A
study by Triton Market Research shows that the medical collagen market in the
Middle East and Africa will develop with a CAGR
of 6.14% in the forecast duration 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this
market include:
• The United Arab Emirates
• Saudi Arabia
• Turkey
• South Africa
• Rest of Middle East & Africa
The
market in the Middle East and Africa is flourishing and several key players are
stepping in to invest in the region with a view to expand their business here. The
wide adoption of collagen products in daily dietary choices is the key market driver
encouraging companies to launch novel & innovative products catering to the
growing customer demand.
Elderly
people often face joint-related issues, and sometimes, muscle pain, lower back
pain, joint pain, and in some cases, even arthritis. Consuming collagen can
help in treating these problems as the protein helps make the bones and joints stronger
and get rid of pain in these body parts.
In
the UAE, medical collagen is used mainly by women for skin repair treatment.
The essential component of hair and skin is collagen. As a person starts aging,
the body generates less collagen. This causes skin dryness, hair fall, and
wrinkle formation. Including collagen supplements in the diet helps keep the
skin hydrated, maintain its elasticity, and reduce dryness & wrinkles. They
also contain amino acids and other vital nutrients that aid hair growth.
Collagen
is being used by the people of Saudi Arabia since the 1990s. Managing chronic
pressure ulcers is a major challenge in wound treatment. Ulcer treatments, which
require the application of medical collagen, are in high demand in the country.
There have been several attempts to define the most effective treatment for
these wounds, one of which includes the use of collagen. The significance of
collagen for healing wounds is well recognized in the KSA, and it plays a crucial
role in all the stages by stimulating new tissue formation and cellular
migration. These factors present an overall positive outlook for the market.
Bone
grafting is a process that involves performing surgery in order to rebuild
damaged bones using transplanted bones. This procedure is also performed in the
field of dentistry as gum tissues are supported by collagen fibers. Type I
collagen, derived from pigs and cows, is used by the dentists for this process.
The studied report assesses the market’s
growth according to application, product, and source. Here, the application
segment comprises bone grafts, tissue scaffolds, hemostats, wound care,
diagnostics, cartilage repair, vascular grafts, and other applications.
The eminent players in the medical
collagen market include Stryker, Gelita, Symatese, Jellagen, Darling
Ingredients Inc, Weishardt, DSM, and Lapi Gelatine.
DSM
is a leading global company that operates in the field of Health, Nutrition, and
Bio-Sciences. Its product Allantoin aids in collagen synthesis, thereby
improving the skin texture. The company has a notable presence in Africa. It
was established in 1902 and has more than 21,000 employees. In FY 2021, the
company’s net sales increased to $10274.56 million from $9048.85 million in FY
2020.
Key deliverables of the report:
·
Market
CAGR during the forecasting years 2022-2028
·
Detailed
data highlighting key insights, industry components, and market strategies
· Comprehensive
information and estimation of the medical collagen market revenue growth in the
Middle East and Africa and its influence on the parent market
·
In-depth
study of forthcoming trends in consumer behavioral patterns
·
A
meticulous analysis of the competitive landscape, vendor scorecard, and
Porter’s Five Forces
· A
wide-ranging study of factors that will challenge the MEA medical collagen
market’s growth during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
1. MIDDLE
EAST AND AFRICA MEDICAL COLLAGEN MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE MEDICAL COLLAGEN INDUSTRY
2.2. KEY
INSIGHTS
2.2.1. SIGNIFICANT
INVESTMENT IN RESEARCH AND DEVELOPMENT ACTIVITIES
2.2.2. EVOLVING
HEALTHCARE INDUSTRY
2.2.3. LAUNCH
OF NEW PRODUCTS DUE TO INCREASED RESEARCH
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. SIDE-EFFECTS
2.4.3. PRODUCT
EFFECTIVENESS
2.4.4. PRICE
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES
2.9.3. PARTNERSHIPS
2.9.4. BUSINESS
EXPANSIONS
2.10. MARKET
DRIVERS
2.10.1. INCREASING
DEMAND FROM THE MEDICAL DEVICES INDUSTRY
2.10.2. GROWING
PUBLIC AWARENESS
2.11. MARKET
CHALLENGES
2.11.1. HEALTH-RELATED
ISSUES
2.11.2. CONSUMERS
LIMITING THE USE OF ANIMAL-BASED PRODUCTS
2.12. MARKET
OPPORTUNITIES
2.12.1. GROWTH
OF THE COSMETICS INDUSTRY
2.12.2. RISING
DEMAND FOR COLLAGEN-RICH FOOD & BEVERAGES
3. MIDDLE
EAST AND AFRICA MEDICAL COLLAGEN MARKET OUTLOOK – BY SOURCE
3.1. BOVINE
3.2. PORCINE
3.3. OTHER
SOURCES
4. MIDDLE
EAST AND AFRICA MEDICAL COLLAGEN MARKET OUTLOOK – BY PRODUCT
4.1. GELATINE
4.2. HYDROLYZED
COLLAGEN
4.3. NATIVE
COLLAGEN
4.4. OTHER
PRODUCTS
5. MIDDLE
EAST AND AFRICA MEDICAL COLLAGEN MARKET OUTLOOK – BY APPLICATION
5.1. WOUND
CARE
5.2. BONE
GRAFTS
5.3. TISSUE
SCAFFOLDS
5.4. CARTILAGE
REPAIR
5.5. HEMOSTATS
5.6. DIAGNOSTICS
5.7. VASCULAR
GRAFTS
5.8. OTHER
APPLICATIONS
6. MIDDLE
EAST AND AFRICA MEDICAL COLLAGEN MARKET – COUNTRY OUTLOOK
6.1. THE
UNITED ARAB EMIRATES
6.2. SAUDI
ARABIA
6.3. TURKEY
6.4. SOUTH
AFRICA
6.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. GELITA
7.2. NITTA
GELATIN INC
7.3. NIPPI
INC
7.4. ITALGEL
7.5. WEISHARDT
7.6. DARLING
INGREDIENTS INC
7.7. LAPI
GELATINE
7.8. TESSENDERLO
GROUP
7.9. DSM
7.10. COLLAGEN
MATRIX INC
7.11. CONNOILS
LLC
7.12. INTEGRA
LIFE SCIENCES
7.13. SYMATESE
7.14. STRYKER
7.15. JELLAGEN
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $
MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: REGULATORY
FRAMEWORK
TABLE 4: LIST OF
ACQUISITIONS
TABLE 5: LIST OF
PRODUCT LAUNCHES
TABLE 6: LIST OF
PARTNERSHIPS
TABLE 7: LIST OF BUSINESS
EXPANSIONS
TABLE 8: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY SOURCE, 2022-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY PRODUCT, 2022-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 11: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $
MILLION)
FIGURE 1: KEY BUYING
IMPACT ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY SOURCE, 2021 & 2028 (IN %)
FIGURE 5: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY BOVINE, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY PORCINE, 2022-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY OTHER SOURCES, 2022-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY PRODUCT, 2021 & 2028 (IN %)
FIGURE 9: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY GELATINE, 2022-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY HYDROLYZED COLLAGEN, 2022-2028 (IN $
MILLION)
FIGURE 11: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY NATIVE COLLAGEN, 2022-2028 (IN $
MILLION)
FIGURE 12: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY OTHER PRODUCTS, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 14: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY WOUND CARE, 2022-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY BONE GRAFTS, 2022-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY TISSUE SCAFFOLDS, 2022-2028 (IN $
MILLION)
FIGURE 17: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY CARTILAGE REPAIR, 2022-2028 (IN $
MILLION)
FIGURE 18: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY HEMOSTATS, 2022-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY DIAGNOSTICS, 2022-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY VASCULAR GRAFTS, 2022-2028 (IN $
MILLION)
FIGURE 21: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $
MILLION)
FIGURE 22: MIDDLE EAST
AND AFRICA MEDICAL COLLAGEN MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 23: THE UNITED
ARAB EMIRATES MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: SAUDI ARABIA
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: TURKEY
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: SOUTH AFRICA
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: REST OF
MIDDLE EAST & AFRICA MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)